24

Mean-variance optimization (MVO) is a 50+ year concept, and perhaps the first seminal idea of quantitative finance. Still, as far as I know, less than 25% of AUM in the US is quantitatively managed. While a small minority of fundamental managers use MVO, that is counterbalanced by statistical arbitrage and HF strategies that often use optimization but not MVO, so the percentage of AUM not allocated using Markowitz' invention is surely not less than 70%. My questions:

  1. if MVO is such a great idea, why after all this time, so few people use it?

  2. if MVO was such a bad idea, how come companies like Axioma, Northfield and Barra still make money off it?

  3. is there there a rationale for the current mixed equilibrium of users and non-users?

A few caveats on what I just said: i) perhaps the first and most important idea in finance is that of state-contingent assets, which is Arrow's; ii) I am focused on the buy side. I believe that optimization is widely used for hedging on the sell side.

gappy
  • 3,593
  • 26
  • 33
  • Quant Guy's first two references in http://quant.stackexchange.com/questions/1985/what-papers-have-progressed-the-field-of-quantitative-finance-in-recent-years-p have very good discussions of the issues with MVO and some interesting solutions. – rhaskett Sep 18 '13 at 23:51

6 Answers6

11

Hey, it's early days yet. After all it is still called MODERN portfolio theory.

I think there are two main issues and they are both really cultural:

1) specifying alphas 2) wild results

Alphas

I agree with Gappy that alphas are the key thing you need to have effectiveness (unless you are doing minimum variance). Having a vector of expected returns is quite a natural thing for quant managers. But it is something foreign to fundamental managers. They have to map their views into a number for each asseet in the universe. That is not necessarily an easy task, and probably would seem like busywork.

I've proposed an optimization that minimizes distance to an ideal target portfolio (subject to constraints). But I haven't exactly been overrun with fundamental managers clamoring for it.

Wild answers

If you take a textbook optimization at its word, you're likely to do some pretty strange things. That has given optimization quite a bad reputation in many quarters. The solution is quite simple: either impose a turnover constraint or increase trading costs to account for the uncertainty of the expected returns (and, less so, the variance matrix). Using trading costs is the better approach but getting the trading costs right is a project in itself.

Patrick Burns
  • 2,142
  • 12
  • 10
4
  1. The biggest problem with mean-variance optimization is that the sensitivity of the estimated covariance matrix.
    Mean variance optimization assumes that one "knows" the covariance of each asset with every other asset, or that the covariance matrix is constant. Without this assumption the MVO framework is not tractable.

  2. Axioma and others do a lot more than just MVO.

  3. None of the approaches are foolproof. An approach that is easy to calculate (MVO), usually has some unpalatable consequences. Things that are difficult to calculate usually provide a false sense of security when it comes to robustness.

Wilmott is a good source to consult for the balance between easy and complex.

glyphard
  • 3,646
  • 1
  • 19
  • 23
  • 5
  • Actually, the biggest problem is the sensitivity with respect to estimated alphas, as shown by Ziemba and Chopra in their 1993, and confirmed by several studies afterwards.

  • I beg to differ. Barra and Axioma do MVO, with a lot of bells and whistles. If MVO is not effective, those added features won't save it.

  • – gappy Feb 09 '11 at 15:58
  • Fully agree. You can take just about any old covariance – NBF May 06 '21 at 10:13